Evidence map›Paper›PMID 42539959›Full record

ArticleSkin health and disease2026

Overcoming measurement challenges in clinical practice: a deep learning-based approach to monocular surface area measurement.

Alfonso Medela, Alberto Sabater, Gerardo Fernández, Taig Mac Carthy, Andy Aguilar, Diego Herrera, Meritxell Falqués, Antonio Martorell

Abstract read
In one paragraph

Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alfonso MedelaDepartment of Medical Data Science, Legit.Health, Bilbao, Spain.
Alberto SabaterDepartment of Medical Data Science, Legit.Health, Bilbao, Spain.
Gerardo FernándezDepartment of Medical Data Science, Legit.Health, Bilbao, Spain.
Taig Mac CarthyDepartment of Clinical Endpoint Innovation, Legit.Health, Bilbao, Spain.
Andy AguilarDepartment of Clinical Endpoint Innovation, Legit.Health, Bilbao, Spain.
Diego HerreraGlobal Clinical Development, Almirall R&D, Sant Feliu de Llobregat, Spain.
Meritxell FalquésGlobal Clinical Development, Almirall R&D, Sant Feliu de Llobregat, Spain.
Antonio MartorellDepartment of Clinical Endpoint Innovation, Legit.Health, Bilbao, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Precise area measurement of body surfaces is essential in clinical trials and clinical practice, particularly for the clinician, to monitor lesion size, assess skin condition severity and determine precise treatment dosage. The inherent difficulty of this task lies in the analysis of irregular surfaces or lesions with complex outlines. Consequently, existing solutions often lack accuracy or rely on expensive and complex technology, limiting their practicality. Objectives: To introduce a cost-effective and accessible artificial intelligence (AI)-driven methodology that accurately measures body surface areas by effectively accounting for surface relief, outline and orientation. Methods: The proposed approach is based on the analysis of monocular smartphone images. By using a set of specific markers, a state-of-the-art depth estimation model and surface triangulation, the area of delimited body surfaces can be measured with high precision. Results: We tested this area measurement technology in controlled and simulated dermatological scenarios where a precise gold standard can be established. The proposed methodology achieves high precision and robustness across different camera configurations and body surfaces of different anatomical complexity. Notably, the proposed approach significantly outperforms traditional methods with a mean absolute error of 20 mm Conclusions: The results consistently demonstrate high accuracy while being an accessible and time-efficient solution. When integrated into an AI-based medical device, this framework improves its usability and broadens its applications to tasks such as lesion severity assessment and clinical trial standardization, making it a valuable tool for clinicians and patients.

Identifiers

PMID42539959
PMCPMC13425033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.